Citadel Advisors’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.5K Buy
45,200
+9,600
+27% +$7.87K ﹤0.01% 12565
2025
Q4
$32.4K Buy
+35,600
New +$34.1K ﹤0.01% 12203
2025
Q1
Sell
-5,000
Closed -$32.2K 15214
2024
Q4
$32.2K Sell
5,000
-32,700
-87% -$159K ﹤0.01% 12799
2024
Q3
$151K Buy
37,700
+25,400
+207% +$105K ﹤0.01% 10557
2024
Q2
$39.5K Buy
+12,300
New +$41.7K ﹤0.01% 12009

Other funds holding MYO

Citadel Advisors's MYO Position: Q3 2025 in Review

Citadel Advisors sold out of Myomo (MYO) in Q3 2025, closing a stake of 324,590 shares — an estimated $472K sold.

Citadel Advisors first reported a position in MYO in Q3 2017 and held it in 15 quarters. The position peaked at $1.27M in Q1 2025. 66 funds tracked by Wall St. Rank hold MYO as of Q3 2025.

  • Citadel Advisors reported no remaining Myomo position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 324,590 Myomo shares in Q3 2025, an estimated $472K.
  • Citadel Advisors first reported a position in Myomo in Q3 2017 and held it in 15 quarters.
  • Citadel Advisors's Myomo position peaked at $1.27M in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Myomo as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.